Some aspects of thyroid dysfunction in thalassemia major patients with severe iron overload

被引:0
|
作者
Rindang, Cynthia K. [1 ]
Batubara, Jose R. L. [1 ]
Amalia, Pustika [1 ]
Satari, Hindra [1 ]
机构
[1] Univ Indonesia, Cipto Mangunkusumo Hosp, Med Sch, Dept Child Hlth, Jl Salemba 6, Jakarta, Indonesia
关键词
thalassemia major; endocrine; primary hypothyroidism; iron overload; iron chelation therapy;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Severe iron overload due to recurrent transfusions for chronic anemia and inadequate iron chelation therapy in thalassemia major patients result in various complications, including hypothyroidism. Currently, there has been no data on the prevalence of hypothyroidism in thalassemia major patients at the Thalassemia Centers, Department of Child Health, Cipto Mangunkusumo Hospital (DCH CMH). Objective To study the prevalence of primary hypothyroidism in thalassemia major patients in the Thalassemia Center, DCH MCH. Methods We performed a cross-sectional, descriptive study. All thalassemia major subjects aged 0-18 years with severe iron overload underwent thyroid function examination. Primary hypothyroidism was defined as either normal (compensated) or decreased (decompensated) free T4 (FT4) levels, along with elevated sensitive thyroid-stimulating hormone (TSH) Results 179 subjects enrolled this study with male: female ratio of 1:1.6. The prevalence of primary hypothyroidism in thalassemia major patients with severe iron overload was 26.8% (48/179). Of those 48, 45 had compensated hypothyroidism and 3 had decompensated hypothyroidism, 25.1% and 1.7% of the total subjects, respectively. Compensated hypothyroidism was observed in 17 subjects aged <10 years and in 28 subjects aged >10 years. All 3 decompensated hypothyroidism cases were > 10 years of age. No relationship was found between the occurrence of primary hypothyroidism and mean pre-transfusion Hb levels (P=0.481, OR 1.30; 95% CI 0.63 to 2.68), elevated serum ferritin levels (P-0.74, OR a89; 95% CI 0.46 to L75), and compliance to iron chelation therapy (P=0.570, OR 0.76; 95% CI 0.35 to 1.65). Based on multivariate analysis, only age of < 10 year-old (P=0.029, OR 0.469; 95% CI 0.23 to 0.93) was significantly associated with primary hypothyroidism. Further analysis using receiver operator curve (ROC) technique found that age of 8.5 year-old was the cutoff value to predict the risk of hypothyroidism. Conclusion The prevalence of primary hypothyroidism in our study is high. The occurrence of hypothyroidism is associated with age.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [21] The influence of hemochromatosis mutations on iron overload of thalassemia major
    Longo, F
    Zecchina, G
    Sbaiz, L
    Fischer, R
    Piga, A
    Camaschella, C
    HAEMATOLOGICA, 1999, 84 (09) : 799 - 803
  • [22] Iron Overload Associated Endocrine Dysfunction Leading to Lower Bone Mineral Density in Thalassemia Major
    Yang, Wen-Ping
    Chang, Hsiu-Hao
    Li, Hung-Yuan
    Lai, Ying-Chuen
    Huang, Tse-Ying
    Tsai, Keh-Sung
    Lin, Kai-Hsin
    Lin, Dong-Tsamn
    Jou, Shiann-Tarng
    Lu, Meng-Yao
    Yang, Yung-Li
    Chou, Shu-Wei
    Shih, Shyang-Rong
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (04): : E1015 - E1024
  • [23] GENDER BUT NOT IRON OVERLOAD INCREASES THE RISK OF BONE DISEASE IN PATIENTS WITH THALASSEMIA MAJOR
    Al-Khabori, K.
    AL-Huneini, N.
    Al-Farsi, S.
    Hussein, S.
    Panjwani, K.
    Al-Maniri, A.
    Daar, F.
    HAEMATOLOGICA, 2012, 97 : 699 - 700
  • [24] Relation between NT-proBNP Levels, Iron Overload, and Early Stage of Myocardial Dysfunction in ß-Thalassemia Major Patients
    Balkan, Can
    Tuluce, Selcen Yakar
    Basol, Gunes
    Tuluce, Kamil
    Ay, Yilmaz
    Karapinar, Deniz Yilmaz
    Gurgun, Cemil
    Bayindir, Oya
    Kavakli, Kaan
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2012, 29 (03): : 318 - 325
  • [25] Amlodipine Reduces Cardiac Iron Overload in Patients with Thalassemia Major: A Pilot Trial
    Fernandes, Juliano Lara
    Sampaio, Erika Fontana
    Fertrin, Kleber
    Coelho, Otavio Rizzi
    Loggetto, Sandra
    Piga, Antonio
    Verissimo, Monica
    Saad, Sara T.
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (09): : 834 - 837
  • [26] Effect of flaxseed intervention on iron overload and its complications in thalassemia major patients
    Fayyaz, Tuba
    Qadeer, Muhammad Imran
    Irfan, Muhammad
    Amjad, Fareeha
    Fatima, Tamseel
    Husnain, Shahida
    NUTRITION & FOOD SCIENCE, 2023, 53 (08): : 1268 - 1278
  • [27] PITUITARY MRI IN CORRELATION WITH IRON OVERLOAD AND HYPOGONADISM IN YOUNG THALASSEMIA MAJOR PATIENTS
    Elalfy, M.
    Adly, A.
    Samir, A.
    HAEMATOLOGICA, 2013, 98 : 169 - 170
  • [28] Pancreatic β Cell Function and its relationship with iron overload in Patients with β-Thalassemia Major
    Zhang, Lina
    Liang, Liyang
    Jiang, Zhuannan
    Meng, Zhe
    Ou, Hui
    Liu, Zulin
    Hou, Lele
    Haung, Siqi
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 391 - 391
  • [29] Compliance with Deferoxamine Therapy and Thyroid Dysfunction of Patients with β-Thalassemia Major in Syria
    Yassouf, M. Yousuf
    Alquobaili, Faizeh
    Kabalan, Younes
    Mukhalalaty, Yasser
    HEMOGLOBIN, 2019, 43 (03) : 218 - 221
  • [30] Hepcidin mutation in a β-thalassemia major patient with persistent severe iron overload despite chelation therapy
    Lorena Duca
    Paola Delbini
    Isabella Nava
    Maria Domenica Cappellini
    Anna Meo
    Internal and Emergency Medicine, 2010, 5 : 83 - 85